Olema Pharmaceuticals (NASDAQ:OLMA) reported quarterly losses of $(0.42) per share. This is a 55.79 percent increase over losses of $(0.95) per share from the same period last year.
Apple And Facebook Clashing Could Be A Major Tech Story Of 2022, Says Expert
Facebook Inc (NASDAQ: FB), or Meta Platforms', foray into smartwatches, wearables and mixed reality headsets is setting up the stage for a major class with Apple Inc (NASDAQ: AAPL), as per Mark G